Abstract
The evolutionarily conserved Wnt signaling pathway regulates physiological hematopoiesis, a process of formation of blood cells and has been shown to play crucial role in the development of both myeloid and lymphoid malignancies. The Wnt signaling pathway can be broadly divided into canonical and non-canonical pathways. In the present study, we investigated the pathobiology of leukemia by studying the expression profile of Wnt proteins, receptors, key signaling intermediates and endogenous Wnt antagonist involved in canonical and non-canonical pathways in the bone marrow (BM) hematopoietic stem/progenitor cell (HSPC) compartment of experimental leukemic mice. Cell adhesion molecule N-Cadherin and leukemic BM microenvironment with reference to Wnt were also studied. We used ENU, a potent carcinogen, to induce leukemia in wild type Swiss albino mice and malignant transformation was cofirmed by peripheral blood and BM studies. Flow cytometric expression analysis revealed profound up-regulation of canonical Wnt3a/β-catenin/CyclinD1 signaling axis along with N-Cadherin whereas down-regulation of non-canonical Wnt5a/Ca2+/CaMKII signaling axis in the leukemic HSPC compartment. Subsequent use of anti-Wnt3a antibody in the in vitro clonogenicity assay uncovered that anti-Wnt3a antibody preferentially inhibited the growth and number of the primitive leukemic hematopoietic CFU-GEMM and BFU-E colonies. Stromal cells derived from the leukemic BM also exhibited aberrant Wnt3a and Wnt5a protein expression. Taken together, alteration of canonical and non-canonical Wnt signaling pathways in the HSPC compartment along with classical Wnt protein expression pattern in the leukemic stromal microenvironment resulted in progression of leukemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- BM:
-
Bone marrow
- HSPC:
-
Hematopoietic stem/progenitor cell
- ENU:
-
N-ethyl-N-nitrosourea
- MPO:
-
Myeloperoxidase
- NSE:
-
Nonspecific-esterase
- Ctrl:
-
Control
- Leuk:
-
Leukemia
- CFU-GEMM:
-
Colony-forming unit of granulocyte/erythrocyte/macrophage/megakaryocyte
- BFU-E:
-
Burst-forming unit of erythroid cells
- CFU-GM:
-
Colony-forming unit of granulocyte/macrophage
- CFU-G:
-
Colony-forming unit of granulocyte
- CFU-E:
-
Colony-forming unit of erythroid cells
References
Anthony BA, Link DC (2014) Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol 35(1):32–37. https://doi.org/10.1016/j.it.2013.10.002
Askmyr M, Quach J, Purton LE (2011) Effects of the bone marrow microenvironment on hematopoietic malignancy. Bone 48(1):115–120. https://doi.org/10.1016/j.bone.2010.06.003
Bakker ERM, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R (2013) Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Carcinogenesis 34(11):2629–2638. https://doi.org/10.1093/carcin/bgt215
Basak P, Chatterjee S, Das P, Das M, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S (2010) Leukemic stromal hematopoietic microenvironment negatively regulates the normal hematopoiesis in mouse model of leukemia. Chin J Cancer 29(12):969–979. https://doi.org/10.5732/cjc.010.10431
Bellon M, Ko NL, Lee MJ, Yao Y, Waldmann TA, Trepel JB, Nicot C (2013) Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood 121(25):5045–5054. https://doi.org/10.1182/blood-2012-07-439109
Bigas A, Guiu J, Gama-Norton L (2013) Notch and Wnt signaling in the emergence of hematopoietic stem cells. Blood Cells Mol Dis 51(4):264–270. https://doi.org/10.1016/j.bcmd.2013.07.005
Bordonaro M, Tewari S, Cicco CE, Atamna W, Lazarova DL (2011) A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells. PLoS One 6(11):e27308. https://doi.org/10.1371/journal.pone.0027308
Brenner AK, Nepstad I, Bruserud Ø (2017) Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms. Front Immunol 8:106. https://doi.org/10.3389/fimmu.2017.00106
Chaklader M, Law S (2015) Alteration of hedgehog signaling by chronic exposure to different pesticide formulations and unveiling the regenerative potential of recombinant sonic hedgehog in mouse model of bone marrow aplasia. Mol Cell Biochem 401:115. https://doi.org/10.1007/s11010-014-2299-5
Chaklader M, Pan A, Law A, Chattopadhayay S, Chatterjee R, Law S (2013) Differential remodeling of cadherins and intermediate cytoskeletal filaments influence microenvironment of solid and ascitic sarcoma. Mol Cell Biochem 382:293–306. https://doi.org/10.1007/s11010-013-1750-3
Chatterjee S, Basak P, Das M, Das P, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S (2009) Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation. J Stem Cells 4(3):179–189
Chatterjee R, Chattopadhyay S, Law S (2016a) Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice. Leuk Res 47:70–77. https://doi.org/10.1016/j.leukres.2016.05.014
Chatterjee R, Chattopadhyay S, Sanyal S, Daw S, Law S (2016b) Pathophysiological scenario of hematopoietic disorders: a comparative study of aplastic anemia, myelodysplastic syndrome and leukemia in experimental animals. Proc Zool Soc 69(1):114–124. https://doi.org/10.1007/s12595-014-0132-5
Chatterjee R, Chattopadhyay S, Law S (2016c) Deregulation of vital mitotic kinase–phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia. Mol Cell Biochem 422(1–2):121–134. https://doi.org/10.1007/s11010-016-2811-1
Chattopadhyay S, Chatterjee R, Law S (2016a) Noncanonical Wnt5a-Ca(2+)-NFAT signaling axis in pesticide induced bone marrow aplasia mouse model: A study to explore the novel mechanism of pesticide toxicity. Environ Toxicol 31(10):1163–1175. https://doi.org/10.1002/tox.22123
Chattopadhyay S, Chaklader M, Chatterjee R, Law A, Law S (2016b) Differential expression of mitotic regulators and tumor microenvironment influences the regional growth pattern of solid sarcoma along the cranio-caudal axis. Exp Cell Res 340(1):91–101. https://doi.org/10.1016/j.yexcr.2015.11.027
Daw S, Chatterjee R, Law A, Law S (2016) Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome. Chem Biol Interact 260:176–185. https://doi.org/10.1016/j.cbi.2016.10.010
De A (2011) Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin 43(10):745–756. https://doi.org/10.1093/abbs/gmr079
Fleming HE, Janzen V, Celso CL, Guo J, Leahy KM, Kronenberg HM, Scadden DT (2008) Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2(3):274–283
Florian MC, Nattamai KJ, Dörr K, Marka G, Uberle B, Vas V, Eckl C, Andrä I, Schiemann M, Oostendorp RA, Scharffetter-Kochanek K, Kestler HA, Zheng Y, Geiger H (2013) A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing. Nature 503(7476):392–396. https://doi.org/10.1038/nature12631
Greim H, Kaden DA, Larson RA, Palermo CM, Rice JM, Ross D, Snyder R (2014) The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment. Ann N Y Acad Sci 1310(1): 7–31. https://doi.org/10.1111/nyas.12362
Guo ZY, Hao XH, Tan FF, Pei X, Shang LM, Jiang XL, Yang F (2011) The elements of human cyclin D1 promoter and regulation involved. Clin Epigenetics 2(2):63–76. https://doi.org/10.1007/s13148-010-0018-y
Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131–139. https://doi.org/10.1128/MCB.23.1.131-139.2003
Kim AD, Stachura DL, Traver D (2014) Cell signaling pathways involved in hematopoietic stem cell specification. Exp Cell Res 329(2):227–233. https://doi.org/10.1016/j.yexcr.2014.10.011
Law S, Maiti D, Palit A, Majumder D, Basu K, Chaudhuri S, Chaudhuri S (2001) Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach. Immunol Lett 76(3):145–152
Lento W, Congdon K, Voermans C, Kritzik M, Reya T (2013) Wnt Signaling in Normal and Malignant Hematopoiesis. Cold Spring Harb Perspect Biol 5(2):a008011. https://doi.org/10.1101/cshperspect.a008011
Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN (2003) Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4(5):349–360
Liu N, Shi HG, Zhang W, Gu B (2016) The crosstalk between canonical and noncanonical Wnt signaling pathway in osteoblast differentiation of periodontal ligament stem cells in inflammatory microenvironments. Zhonghua Kou Qiang Yi Xue Za Zhi 51(11):673–679. https://doi.org/10.3760/cma.j.issn.1002-0098.2016.11.007
Luis TC, Ichii M, Brugman MH, Kincade P, Staal FJ (2012) Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia 26:414–421. https://doi.org/10.1038/leu.2011.387
Many AM, Brown AMC (2014) Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres. PLoS One 9(7):e101800. https://doi.org/10.1371/journal.pone.0101800
Martín V, Valencia A, Agirre X, Cervera J, San Jose-Eneriz E, Vilas-Zornoza A, Rodriguez-Otero P, Sanz MA, Herrera C, Torres A, Prosper F, Román-Gómez J (2010) Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia. Cancer Sci 101(2):425–432. https://doi.org/10.1111/j.1349-7006.2009.01413.x
Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115. https://doi.org/10.1371/journal.pbio.0040115
Mikels A, Minami Y, Nusse R (2009) Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling. J Biol Chem 284(44):30167–30176. https://doi.org/10.1074/jbc.M109.041715
Minami Y, Oishi I, Endo M, Nishita M (2010) Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn 239(1):1–15. https://doi.org/10.1002/dvdy.21991
Ng OH, Firtina S, Can I, Karakaş Z, Ağaoğlu L, Doğru Ö, Celkan T, Akçay A, Yıldırmak Y, Timur Ç, Özbek U, Sayitoğlu M (2015) A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia. Turk J Haematol 32(2):127–135. https://doi.org/10.4274/tjh.2013.0296
Pawar RD, Cui W, Lin TL, Aljitawi OS (2015) N-Cadherin Immunoexpression In Patients With Acute Myeloid Leukemia. Blood 126:4944
Pereira JA, Law S (2018) Microenvironmental scenario of the bone marrow of inorganic arsenic-Exposed experimental mice. Biol Trace Elem Res 181(2):304–313. https://doi.org/10.1007/s12011-017-1022-2
Pinzón-Daza ML, Salaroglio IC, Kopecka J, Garzòn R, Couraud PO, Ghigo D, Riganti C (2014) The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. J Cereb Blood Flow Metab 34(8):1258–1269. https://doi.org/10.1038/jcbfm.2014.100
Polakis P (2012) Wnt Signaling in Cancer. Cold Spring Harb Perspect Biol 4(5):a008052. https://doi.org/10.1101/cshperspect.a008052
Qiu S, Jia Y, Xing H, Yu T, Yu J, Yu P, Tang K, Tian Z, Wang H, Mi Y, Rao Q, Wang M, Wang J (2014) N-Cadherin and Tie2 positive CD34+ CD38−CD123+ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice. Leuk Res 38(5):632–637. https://doi.org/10.1016/j.leukres.2014.03.007
Ramakrishnan A, Torok-Storb B, Pillai MM (2013) Primary marrow-derived stromal cells: isolation and manipulation. In: Stem Cell Niche. Humana Press, Totowa, NJ, pp 75–101
Richter J, Traver D, Willert K (2017) The role of Wnt signaling in hematopoietic stem cell development. Crit Rev Biochem Mol Biol 52(4):414–424. https://doi.org/10.1080/10409238.2017.1325828
Schaniel C, Sirabella D, Qiu J, Niu X, Lemischka IR, Moore KA (2011) Wnt inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood 118(9):2420–2429
Schreck C, Bock F, Grziwok S, Oostendorp RA, Istvánffy R (2014) Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche. Ann N Y Acad Sci 1310:32–43. https://doi.org/10.1111/nyas.12384
Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The CyclinD1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96(10):5522–5527
Stacey DW (2003) Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 15(2):158–163
Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899–908. https://doi.org/10.1083/jcb.200303158
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 30 114(5):937–951. https://doi.org/10.1182/blood-2009-03-209262
Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA (2010) The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327(5973):1650–1653. https://doi.org/10.1126/science.1186624
Weir EG, Ansari-Lari MA, Batista DA, Griffin CA, Fuller S, Smith BD, Borowitz MJ (2007) Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 21(11):2264–2270. https://doi.org/10.1038/sj.leu.2404848
Wu X, McMurray CT (2001) Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein. J Biol Chem 276(3):1735–1741. https://doi.org/10.1074/jbc.M006727200
Yan L, Du Q, Yao J, Liu R (2016) ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling. Exp Ther Med 12(6):4128–4134. https://doi.org/10.3892/etm.2016.3883
Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q (2007) WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 110:4130–4131. https://doi.org/10.1182/blood-2007-06-094870
Ysebaert L, Chicanne G, Demur C, De Toni F, Prade-Houdellier N, Ruidavets JB, Mansat-De Mas V, Rigal-Huguet F, Laurent G, Payrastre B, Manenti S, Racaud-Sultan C (2006) Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 20(7):1211–1216. https://doi.org/10.1038/sj.leu.2404239
Yuan Y, Niu CC, Deng G, Li ZQ, Pan J, Zhao C, Yang ZL, Si WK (2011, 27(1)) The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Int J Mol Med:63–69. https://doi.org/10.3892/ijmm.2010.560
Zang S, Liu N, Wang H, Wald DN, Shao N, Zhang J, Ma D, Ji C, Tse W (2014) Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation. BMC Cancer 14(1):886. https://doi.org/10.1186/1471-2407-14-886
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36:1461–1473. https://doi.org/10.1038/onc.2016.304
Zhang B, Li M, McDonald T, Holyoake TL, Moon RT, Campana D, Shultz L, Bhatia R (2013) Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt–β-catenin signaling. Blood 121(10):1824–1838. https://doi.org/10.1182/blood-2012-02-412890
Zhi L, Gao Y, Yu C, Zhang Y, Zhang B, Yang J, Yao Z (2016) N-cadherin aided in maintaining the characteristics of leukemic stem cells. Anat Rec (Hoboken) 299(7):990–998. https://doi.org/10.1002/ar.23345
Zhou HR, FU HY, WU DS, Zhang YY, Huang SH, Chen CJ, Yan JG, Huang JL, Shen JZ (2017) Relationship between epigenetic changes in Wnt antagonists and acute leukemia. Oncol Rep 37:2663–2671. https://doi.org/10.3892/or.2017.5509
Acknowledgements
Authors are thankful to the Director, Calcutta School of Tropical Medicine for supporting the work. We are also thankful to Leica Microsystem and Dept. of Biological Sciences, Presidency University for providing facilities of confocal microscope.
Funding
This work was supported by the INSPIRE Fellowship, Dept. of Science and Technology, Govt. of India [Fellowship Number: DST/INSPIRE Fellowship/2013/283(IF130354)]; and the Council for Scientific and Industrial Research (CSIR), Govt. of India [Grant Number: No. 37(1429)/10/EMRII].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors unanimously declare no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Chattopadhyay, S., Chaklader, M. & Law, S. Aberrant Wnt Signaling Pathway in the Hematopoietic Stem/Progenitor Compartment in Experimental Leukemic Animal. J. Cell Commun. Signal. 13, 39–52 (2019). https://doi.org/10.1007/s12079-018-0470-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-018-0470-6